Pharmacogenomic Testing for SSRIs: How CYP2C19 and CYP2D6 Affect Side Effects
Pharmacogenomic testing for CYP2C19 and CYP2D6 helps predict how your body processes SSRIs, reducing side effects and failed treatments. Learn how your genes affect antidepressant response and what to do next.